The antagnoist action of ouabain conjugated peptide for ouabains inhibition on Na+,K+-ATPase

张明娟,吕卓人,冯新利,雷在中
DOI: https://doi.org/10.3969/j.issn.1671-8259.2004.03.010
2004-01-01
Abstract:Objective: To obtain ouabain conjugated peptides (OCP) for blockage or antagonist actions of endogenous ouabain (EO) on sodium pump, so as to provide theoretical and experimental bases for hypertension therapy. Methods: We screened the phage and displayed 12-peptide library by biopanning for OCP. The DNA sequences of each selected peptide were determined and the amino acid sequences were deduced. We selected the highest consistence of the polypeptide, which was synthesized by peptide synthesizer. Bioactivity of OCP was measured by erythrocyte 86Rb uptake. Results: Leu-Leu-Ala-Asp-Thr-Thr-His-His- Arg-Pro-Trp-Thr had the highest consistence of peptide sequence, which was the sequence of synthetic peptide. The result of erythrocyte 86Rb uptake verified that OCP was capable of suppressing the inhibitiory action between ouabain and sodium pump on the surface of erythrocyte, which improved the erythrocyte 86Rb uptake from 60% to 80%. The result showed that the efficiency was in a dose-dependent manner. Conclusion: The results not only obtain distinctive OCP, but also supply a valuable way in treatment of hypertension as well as diagnosis and therapy of EO-related diseases.
What problem does this paper attempt to address?